Weight loss treatments linked to lower risk of obesity-related #cancers in people without #diabetes. New research in @Annals_Oncology @myESMO, paper free access: bit.ly/4fJlJtN
Recent data show that glucagon-like peptide-1 receptor agonist (GLP-1RA) use is associated
with decreased cancer incidence in diabetic and obese patients. However, there have
been no studies exclusive...
